Vandenbroucke lab

Research field: Gut and brain barriers in inflammatory diseases @UGent @VIBLifeSciences @InflamResCen. Headed by @vdb_Roos

[Vandenbroucke lab @Vdb_lab]

Last Friday, @InflamResCen hosted IRC Science Day:

A day packed with inspiring talks that showcased the diverse work of our institute. Science also met creativity during the Science Fair 🎡 We had a blast putting a creative spin on what we do in the lab!

[Vandenbroucke lab @Vdb_lab]

Our findings suggest that Smpd3's role in EV biogenesis might vary depending on cell type or species, indicating its effects are not universally consistent across different cellular contexts.

[Vandenbroucke lab @Vdb_lab]

Thrilled to share our paper exploring the role of Smpd3 in EV biogenesis is now published in @ISEV_JExBio!

🔬We took a novel approach beyond common pharmacological inhibitors by creating both full-body and conditional Smpd3 KO mice. Read more below👇

https://t.co/p0LW3dUFy5

[Vandenbroucke lab @Vdb_lab]

Contrary to expectations, Smpd3 deficiency did not affect EV release, both in vivo and in specific cells such as mixed cortical cultures and bone marrow derived macrophages.

[BBBelgium @BBBelgium_]

A huge thank you to everyone who joined us at the 3rd #BBBelgium24 Symposium! 🙌 Inspiring talks, posters, and discussions made it an unforgettable day. Also thanks to our sponsors for making it possible! We can't wait to see you all at the next edition!

[BBBelgium @BBBelgium_]

🚀 And we're off! Welcome to #BBBelgium24, ready for amazing talks, posters and networking!

[Vandenbroucke lab @Vdb_lab]

Only 3 more nights! Excited to welcome everyone to our institute for what promises to be an inspiring day! #BBBelgium24

[BBBelgium @BBBelgium_]

We're in full swing with the final preparations for the #BBBelgium24 symposium coming Monday! Can't wait to welcome you all in Ghent! 👀

[BBBelgium @BBBelgium_]

🚨 Last chance! 🚨 Early bird registration for the 3rd #BBBelgium2024 Symposium closes TODAY! Don’t miss out on securing your spot at a reduced rate. Register now on https://t.co/ESUOGYfVKf and join us on October 14, 2024, in Ghent!

[BBBelgium @BBBelgium_]

🗣️ Only one month left to submit your oral abstract for the 3rd BBBelgium Symposium #BBBelgium24!
🐦 Early bird registration closes in just 3 weeks, don't miss out!

[Daan Verhaege @DaanVerhaege]

Check out part of my PhD work in our @biorxiv_neursci paper: Newly discovered base barrier cells provide compartmentalization of choroid plexus, brain and CSF. @Vdb_lab and many awesome collaborators.

https://t.co/6LWNpUDw7U

Hope to share the revised version soon!

[Vandenbroucke lab @Vdb_lab]

Excited to expand and share our neuroimmunology knowledge at the 18th European School Neuroimmunology Course @ISNI_neuro in Hasselt! 🤓🧠With presentations by lab members @PieterDujardin & @hannah_lernout @IBDUnitGent

[Vandenbroucke lab @Vdb_lab]

Great that we could contribute to this work! @charyssevdd @vdb_roos

[VIB @VIBLifeSciences]

💡Exciting news from the Haesler lab (@__NERF)! The scientists developed unique microfluidic interfaces in preclinical models, providing a powerful new way to access brain fluids or deliver drugs with great translational potential. Read more: https://t.co/Ivu4pZdJk3

[Vandenbroucke lab @Vdb_lab]

Enjoying after-work sunshine ☀️ confirmed that lab skills do not translate to Kubb skills 😎

[Vandenbroucke lab @Vdb_lab]

Excited to host the 3rd edition of the @BBBelgium_ symposium at our home turf. Save the date: October 14th! Can't wait to see many of you there!

[BBBelgium @BBBelgium_]

‼️ Thrilled to announce our 3rd Brain Barriers Belgium Symposium, taking place October 14th 2024 in the vibrant City of Ghent @InflamResCen! 🗓️ Save the date 🗓️ for an enriching day dedicated to breaking barriers in brain research for both local and international researchers.

[The Science of Parkinson's @ScienceofPD]

Results of the GUT-PARFECT study have been published: A double-blind, placebo-controlled, randomised, phase 2 trial evaluating the clinical effects & safety of a single faecal microbiota transplantation (FMT) in 46 patients with early-stage #Parkinsons
https://t.co/i70Z3U10AS

[Arnout Bruggeman @ArnoutBruggeman]

New scientific goal reached… Having your study highlighted by @ScienceofPD 🙏🙏

[Vandenbroucke lab @Vdb_lab]

Great Oncopoint symposium by @crighent, where @vdb_roos and Xenia highlighted our interest in the choroid plexus 🧠🎯

[Arnout Bruggeman @ArnoutBruggeman]

What a week! The results of our clinical trial with FMT in Parkinson's disease were published and this received a lot of attention in the local media. Today we presented our results at the yearly conference of the Flemish patient organisation (@parkinsonliga).